Susquehanna International Group
VTYX

Susquehanna International Group’s Ventyx Biosciences VTYX Stock Holding History

Susquehanna International Group’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-194,600
Closed -$1.76M – 14203
2025
Q4 		$1.76M Buy
194,600
+109,100
+128% +$815K ﹤0.01% 5917
2025
Q3 		$266K Buy
85,500
+58,100
+212% +$154K ﹤0.01% 10398
2025
Q2 		$58.6K Buy
+27,400
New +$44.3K ﹤0.01% 12063
2025
Q1 		– Sell
-25,000
Closed -$54.8K – 13554
2024
Q4 		$54.8K Buy
25,000
+15,000
+150% +$34K ﹤0.01% 11639
2024
Q3 		$21.8K Sell
10,000
-181,700
-95% -$418K ﹤0.01% 11614
2024
Q2 		$443K Buy
191,700
+46,600
+32% +$194K ﹤0.01% 8559
2024
Q1 		$798K Buy
145,100
+72,600
+100% +$332K ﹤0.01% 7412
2023
Q4 		$179K Sell
72,500
-48,300
-40% -$459K ﹤0.01% 10794
2023
Q3 		$4.2M Buy
120,800
+85,500
+242% +$2.96M ﹤0.01% 3834
2023
Q2 		$1.16M Sell
35,300
-41,900
-54% -$1.44M ﹤0.01% 6342
2023
Q1 		$2.59M Buy
+77,200
New +$3M ﹤0.01% 4619
2022
Q4 		– Sell
-26,400
Closed -$922K – 13799
2022
Q3 		$922K Buy
+26,400
New +$585K ﹤0.01% 6837

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's VTYX Position: Q1 2026 in Review

Susquehanna International Group sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 1,118,275 shares — an estimated $10.1M sold.

Susquehanna International Group first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $10.1M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Susquehanna International Group reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 1,118,275 Ventyx Biosciences shares in Q1 2026, an estimated $10.1M.
  • Susquehanna International Group first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
  • Susquehanna International Group's Ventyx Biosciences position peaked at $10.1M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.